Anti-Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) Polyclonal Antibody Homo sapiens (Human) Protein, Antibody, Assaykit, Service

P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1

Add to Cart Distributors
Overview
Properties
  • Ig Type IgG, Potency n/a
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Excitation LaserNone
  • Vol. per test1-5 µl
  • Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
  • TraitsLiquid
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Anti-Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) Polyclonal Antibody Packages (Simulation)
  • Anti-Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) Polyclonal Antibody Packages (Simulation)
  • Anti-Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) Polyclonal Antibody HepG2 human hepatocellular carcinoma cell line was stained with rabbit Anti-human CDKN2A Polyclonal Antibody (Catalog # FAA794Hu01, filled red histogram) or Isotype control antibody (Catalog # IS067-Rb01, filled green histogram), followed by APC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog # SAA544Rb15). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100.
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Usage

For flow cytometry, the suggested use of this reagent is 1-5 µl per 10^6 cells in 100 µl volume.
Optimal working dilutions could be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Giveaways

Citations

  • Comparison of Selected Protein Levels in Tumour and Surgical Margin in a Group of Patients with Oral Cavity Cancerpubmed:28421310
  • Development of core-shell nanocarrier system for augmenting piperine cytotoxic activity against human brain cancer cell linePubmed:29597041
  • Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetesPubmed: 31732824
  • Tumor suppressor genes are differentially regulated with dietary folate modulations in a rat model of hepatocellular carcinomaPubmed: 32974833

Recommend products